Measurement of bone mineral density in stable COPD patients using ultrasound densitometry: prevention is better than cure

Authors

  • M. Arif Ali Department of Pulmonary Medicine, Mahatma Gandhi Mission Medical College, Kamothe, Navi Mumbai, Maharashtra, India
  • Vijay Tukaram Salve Department of Pulmonary Medicine, ESIC Medical College, Chennai, Tamil Nadu, India

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20174121

Keywords:

Stable COPD, Bone mineral density, Osteopenia, Osteoporosis

Abstract

Background: COPD is a multisystem disorder and three or more comorbidities are associated with poor prognosis. Osteoporosis is one of the major comorbidity and is associated with an impact on the primary dysfunction in COPD. Bone Mineral density measures strength of the skeletal system and ultrasound based BMD measurement is a cheap, cost effective intervention which is also free from ionizing radiation. Ultrasound densitometer BMD measurement can be utilized for screening of osteoporosis in COPD patients.

Methods: 50 stable COPD (diagnosed as per GOLD guideline) patients attending a post graduate institute in Mumbai were enrolled for the study and bone mineral density was measured using ultrasonography BMD scan of calcaneum.

Results: Among 50 enrolled COPD patients, 27 (54%) patients had osteopenia and 14 (28%) were osteoporotic.9 (64.3%) female and 18 (50%) male COPD patients had osteopenia. 4 (28.6%) females and 10 (27.8%) males were osteoporotic.

Conclusions: Considering the additional burden of osteoporosis on management of COPD, it is advisable to measure BMD to formulate strategies to prevent fractures in COPD patients.

 

Author Biographies

M. Arif Ali, Department of Pulmonary Medicine, Mahatma Gandhi Mission Medical College, Kamothe, Navi Mumbai, Maharashtra, India

Assistant Professor (department of Pulmonary medicine),Mahatma Gandhi Mission medical College, Navi Mumbai, India.

Vijay Tukaram Salve, Department of Pulmonary Medicine, ESIC Medical College, Chennai, Tamil Nadu, India

Associate professor, Department of Pulmonary medicine. ESIC Medical College,K.K, Nagar, Chennai, India.

References

Global Initiative for Chronic Obstructive Lung Disease. Available at: www.copdgold.org.- GOLD 2017. Accessed on 10 November 2016.

Cooper, Barker DJ, Morris J, Briggs RS. Osteoporosis falls and age in fracture of the proximal femur. Br Med J. 1987;295:13-5.

Schnell K, Weiss CO, Lee T, Krishnan JA, Leff B, Wolff JL, et al. The prevalence of clinically relevant comorbid conditions in patients with COPD: a cross-sectional study using data from NHANES 1999–2008. BMC Pulm Med. 2012;12(1):26.

Loke YK, Cavallazzi R, Singh S. Risk of fractures with inhaled corticosteroids in COPD: systematic review and meta-analysis of randomized controlled trials and observational studies. Thorax. 2011;66(8):699–708.

Toogood JH, Baskerville JC, Markov AE, Hodsman AB, Fraher LJ, Jennings B, et al. Bone mineral density and the risk of fracture in patients receiving long-terminhaled steroid therapy for asthma. J Allergy Clin Immunol. 1995;96:157–66.

Wisniewski AF, Lewis SA, Green DJ, Maslanka W, Burrell H, Tattersfield AE. Cross sectional investigation of the effects of inhaled corticosteroids on bonedensity and bone metabolism in patients with asthma. Thorax. 1997;52:853–60.

Bai P, Sun Y, Jin J, Hou J, Li R, Zhang Q, et al. Disturbance of the OPG/RANK/RANKL pathway and systemic inflammation in COPD patients with emphysema and osteoporosis. Respir Res. 2011;12:157.

Braun T, Schett G. Pathways for bone loss in inflammatory disease. Curr Osteoporos Rep. 2012;10(2):101–8.

Mundy GR. Osteoporosis and inflammation. Nutr Rev. 2007;65(12):147–51.

Krall EA, Dawson-Hughes B. Smoking and bone loss among postmenopausal women. J Bone Miner Res. 1991;6:331–7.

Seeman E. The effects of tobacco and alcohol use on bone. In: Marcus R, Feldman D, Kelsey J, eds. Osteoporosis. NewYork, NY: Academic Press; 1996: 577–597.

Langton CM, Palmer SB, Porter RW. The measurement of broadband ultrasonic attenuation in cancellouhone. Eng Med. 1984;13(2):9-91.

Madsen H, Brixen K, Hallal. Screening, prevention and treatment of osteoporosis in patients with chronic obstructive pulmonary disease –A population based database study. Cli Respir J. 2010:4(1).22-9.

Seeman E, Melton LJ, O’Fallon WM, Riggs BL. Risk factors for spinal osteoporosis in men. Am J Med. 1983;75:977–83.

Daniell HW. Osteoporosis of the slender smoker. Arch Intern Med. 1976;136:298–304.

Sparrow D, Beausoleil NI, Garvey AJ, Rosner B, Silbert JE. The influence of cigarette smoking and age on bone loss in men. Arch Environ Health. 1982;37:246–9.

WHO (2007). Scientific group on the prevention and management of osteoporosis (2000): Geneva, Switzerland (2003). ‘‘Prevention and management of osteoporosis: report of a WHO scientific group’’.

Heaney RP. Pathophysiology of osteoporosis. Endocrinal Metab Clin North Am. 1998;27:255–65.

Hurley DL, Khosla S. Update on primary osteoporosis. Mayo Clin Proc. 1997;72:943–9.

Reid IR, Ames R, Evans MC, Sharpe S, Gamble G, France JT, et al. Determinants of total body and regional bone mineral density in normal postmenopausal Women: a key role for fat mass. J Clin Endocrinol Metab. 1992;75(1):45-51.

Inoue D, Watanabe R, Okazaki R. COPD and osteoporosis: links, risks, and treatment challenges. Int J COPD. 2016:11:637–48.

Graat-Verboom L, Wouters EFM, Smeenk FW. Current status of research on osteoporosis in COPD: a systematic review. Eur Respir J. 2009;34:209–18.

Ryan CS, Petkov VI, Adler RA. Osteoporosis in men: the value of laboratory testing. Osteoporos Int. 2011;22(6):1845–53.

Incalzi RA, Caradonna P, Ranieri P. Correlates of osteoporosis in chronic obstructive pulmonary disease. Respir Med. 2000;94:1079–84.

Abu-Bakr SM, Galal Eldin MM, Hafez MR, Salem SM, Qandeel HT. Assessment of osteoporosis in patients with chronic obstructive pulmonary disease. Egyptian J Chest Dis Tuberculosis. 2014;63(2):597–602.

Abbasi M, Zohal M, Atapour B, Yazdi Z. Prevalence of Osteoporosis and Its Risk Factors in Men with COPD in Qazvin. Int J Chronic Diseases. 2016;2016:4038530.

Maggi S, Siviero P, Gonnelli S, Schiraldi C, Malavolta N, Nuti R. Osteoporosis risk in patients with chronic obstructive pulmonary disease: the EOLO study. J Clin Densitom. 2009;12:345–52.

Mineo TC, Ambrogi V, Mineo D, Fabbri A, Fabbrini E, Massoud R. Bone mineral density improvement after lung volume reduction surgery forsevere emphysema. Chest. 2005;127:1960–6.

Watanabe R, Tanaka T, Aita K, Hagiya M, Homma T, Yokosuka K, et al. Osteoporosis is highly prevalent in Japanese males with chronic obstructive pulmonary disease and is associated with deteriorated pulmonary function. J Bone Miner Metab. 2015;33(4):392–400.

Graat-Verboom L, Spruit MA, van den Borne BE, Smeenk FW, Martens EJ, Lunde R, et al. Correlates of osteoporosis in chronic obstructive pulmonary disease: an underesti¬mated systemic component. Respir Med. 2009;103(8):1143–51.

Majumdar SR, Villa-Roel C, Lyons KJ, Rowe BH. Prevalence and predictors of vertebral fracture in patients with chronic obstructive pulmonary disease. Respir Med. 2010;104(2):260–6.

Ramachandran K, Mani SK, Gopal GK, Rangasami S. Bone Mineral Abnormalities in Patients with COPD. J Clin Diagnostic Res. 2016;10(9):32-4.

Bhattacharyya P, Paul R, Ghosh M, Dey R, Dey R, Barooah N, et al. Prevalence of osteoporosis and osteopenia in advanced chronic obstructive pulmonary disease patients. Lung India. 2011;28(3):184-6.

Law R, Hackshaw AK. A meta-analysis of cigarette smoking, bone mineral. Density and risk of hip fracture: recognition of a major effect. BMJ. 1997;315:841.

Slemenda CW, Hui SL, Longcope C. Cigarette smoking, obesity, and bone mass. J Bone Miner Res. 1989;4:737–41.

Boyer L, Chouaïd C, Bastuji-Garin S, Marcos E, Margarit L, Le Corvoisier P, et al. Aging-Related Systemic Manifestations in COPD Patients and Cigarette Smokers. PLoS ONE. 2015;10(3):e0121539.

Jaramillo JD, Wilson C, Stinson DS, Lynch DA, Bowler RP, Lutz S, et al. Reduced Bone Density and Vertebral Fractures in Smokers. Men and COPD Patients at Increased Risk. Ann Am Thorac Soc. 2015;12(5):648-56.

Genant HK, Engelke K, Fuerst T, Gluer CC, Grampp S, Harris ST, et al. Noninvasive assessment of bone mineral and structure: state of the art. J Bone Miner Res. 1996;11:707-30.

Downloads

Published

2017-09-22

How to Cite

Ali, M. A., & Salve, V. T. (2017). Measurement of bone mineral density in stable COPD patients using ultrasound densitometry: prevention is better than cure. International Journal Of Community Medicine And Public Health, 4(10), 3554–3560. https://doi.org/10.18203/2394-6040.ijcmph20174121

Issue

Section

Original Research Articles